Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Inflammatory Bowel Diseases

Free Subscription 23.05.2022 1 Aliment Pharmacol Ther 4 BMC Gastroenterol 3 Dig Dis Sci 2 Dis Colon Rectum 3 Gastroenterol Hepatol 6 Gastroenterology 7 Inflamm Bowel Dis 17 J Crohns Colitis 3 Lancet Gastroenterol Hepatol 1 Mediators Inflamm

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. KO KL, Lam YF, Cheung KS, Hung IF, et al
   Clinical trial: intra-dermal hepatitis B vaccination with topical imiquimod versus intra-muscular hepatitis B vaccination in inflammatory bowel disease patients.
   Aliment Pharmacol Ther. 2022 May 11. doi: 10.1111/apt.16970.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

2. ZHANG Z, Yu X, Fang N, Long X, et al
   Can visceral adipose tissue and skeletal muscle predict recurrence of newly diagnosed Crohn's disease in different treatments.
   BMC Gastroenterol. 2022;22:250.
   PubMed         Abstract available
   
   
3. FREITAS M, de Castro FD, Macedo Silva V, Arieira C, et al
   Ultrasonographic scores for ileal Crohn's disease assessment: Better, worse or the same as contrast-enhanced ultrasound?
   BMC Gastroenterol. 2022;22:252.
   PubMed         Abstract available
   
   
4. BOLLEGALA N, Barwick M, Fu N, Griffiths AM, et al
   Multimodal intervention to improve the transition of patients with inflammatory bowel disease from pediatric to adult care: protocol for a randomized controlled trial.
   BMC Gastroenterol. 2022;22:251.
   PubMed         Abstract available
   
   
5. TANG N, Chen H, Chen R, Tang W, et al
   Combination of serological biomarkers and clinical features to predict mucosal healing in Crohn's disease: a multicenter cohort study.
   BMC Gastroenterol. 2022;22:229.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

6. UCHIYAMA K, Takagi T, Mizushima K, Asaeda K, et al
   Investigation on the Inhibitory Effect of Wnt-5a on Colonic Mucosal Inflammation in Patients with Ulcerative Colitis.
   Dig Dis Sci. 2022 May 19. pii: 10.1007/s10620-022-07537.
   PubMed         Abstract available
   
   
7. GOTTLIEB ZS, Dolinger M, Kayal M, Rao BB, et al
   Clinical Challenge: Proactive Precise Management of Active Ulcerative Colitis During Pregnancy-Advantages of Point-of-Care Intestinal Ultrasound and Therapeutic Drug Monitoring.
   Dig Dis Sci. 2022 May 17. pii: 10.1007/s10620-022-07532.
   PubMed        
   
   
8. SIMSEK-ONAT P, Hizarcioglu-Gulsen H, Ergen YM, Gumus E, et al
   Neutrophil-to-Lymphocyte Ratio: An Easy Marker for the Diagnosis and Monitoring of Inflammatory Bowel Disease in Children.
   Dig Dis Sci. 2022 May 17. pii: 10.1007/s10620-022-07547.
   PubMed         Abstract available
   
   

   
   Dis Colon Rectum

9. BERESNEVA O, Al Jabri AA, Breen E, Kuhnen AH, et al
   What Can an Aging Pouch Tell Us? Outcomes of Ileoanal Pouches Over 20 Years Old.
   Dis Colon Rectum. 2022;65:837-845.
   PubMed         Abstract available
   
   
10. ABBASS MA, Lavryk OA, Hyman N, Liska D, et al
    Nonspecific, Acute Pouchitis in Patients With Familial Adenomatous Polyposis: Less Common Than We Think.
    Dis Colon Rectum. 2022;65:846-850.
    PubMed         Abstract available
    
    

    
    Gastroenterol Hepatol

11. RAMOS L, Ramos-Rodriguez J, Barreda R, Gutierrez-Nicolas F, et al
    Adherence to subcutaneous biologic treatment for inflammatory bowel disease.
    Gastroenterol Hepatol. 2022;45:335-341.
    PubMed         Abstract available
    
    
12. SURIA C, Bosca-Watts MM, Navarro P, Tosca J, et al
    Management of patients with Intestinal Bowel Disease and COVID-19: A review of current evidence and future perspectives.
    Gastroenterol Hepatol. 2022;45:383-389.
    PubMed         Abstract available
    
    
13. MARIA SR, Jesus B, Luis FS, Lara A, et al
    Incidence, and natural history of inflammatory bowel disease in Castilla y Leon: prospective and multicenter epidemiological study.
    Gastroenterol Hepatol. 2022 May 12. pii: S0210-5705(22)00139.
    PubMed         Abstract available
    
    

    
    Gastroenterology

14. CROSS RK, Keefer L
    Chicken or Egg, Mental Health Disorders in Inflammatory Bowel Disease: Does It Matter?
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00454.
    PubMed        
    
    
15. RICCIUTO A, Rauter I, McGovern DPB, Mader RM, et al
    Precision Medicine in Inflammatory Bowel Diseases: Challenges and Considerations for the Path Forward.
    Gastroenterology. 2022;162:1815-1821.
    PubMed        
    
    
16. DELSUPEHE AM, Bourgain C, Bossuyt P
    Subtle Trap for the Inflammatory Bowel Disease Endoscopy Central Reader.
    Gastroenterology. 2022;162:1849-1851.
    PubMed        
    
    
17. HANZEL J, Ma C, Jairath V
    Design of Clinical Trials for Mild to Moderate Crohn's Disease.
    Gastroenterology. 2022;162:1800-1814.
    PubMed        
    
    
18. LIU CY, Girish N, Gomez ML, Dube PE, et al
    Transitional Anal Cells Mediate Colonic Re-epithelialization in Colitis.
    Gastroenterology. 2022;162:1975-1989.
    PubMed         Abstract available
    
    
19. D'HAENS GR, Sandborn WJ, Loftus EV Jr, Hanauer SB, et al
    Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
    Gastroenterology. 2022;162:1876-1890.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

20. MADSEN GR, Bertl K, Pandis N, Stavropoulos A, et al
    The Impact of Periodontitis on Inflammatory Bowel Disease Activity.
    Inflamm Bowel Dis. 2022 May 12. pii: 6584926. doi: 10.1093.
    PubMed         Abstract available
    
    
21. RIZVI A, Trivedi P, Bar-Mashiah A, Plietz M, et al
    Vitamin D Deficiency is Common in Patients with Ulcerative Colitis After Total Proctocolectomy with Ileal Pouch Anal Anastomosis.
    Inflamm Bowel Dis. 2022 May 11. pii: 6584485. doi: 10.1093.
    PubMed        
    
    
22. DE KRIJGER M, Carvalho B, Rausch C, Bolijn AS, et al
    Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 May 11. pii: 6584483. doi: 10.1093.
    PubMed         Abstract available
    
    
23. KAWASHIMA K, Oshima N, Kishimoto K, Kataoka M, et al
    Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission.
    Inflamm Bowel Dis. 2022 May 18. pii: 6588003. doi: 10.1093.
    PubMed         Abstract available
    
    
24. SLEUTJES JAM, Roeters van Lennep JE, van der Woude CJ, de Vries AC, et al
    Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation.
    Inflamm Bowel Dis. 2022 May 19. pii: 6589576. doi: 10.1093.
    PubMed         Abstract available
    
    
25. GOODYEAR BG, Heidari F, Ingram RJM, Cortese F, et al
    Multimodal Brain MRI of Deep Gray Matter Changes Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 May 19. pii: 6589553. doi: 10.1093.
    PubMed         Abstract available
    
    
26. GOLD SL, Rabinowitz LG, Manning L, Keefer L, et al
    High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course.
    Inflamm Bowel Dis. 2022 May 19. pii: 6589577. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

27. SUN TY, Li YQ, Zhao FQ, Sun HM, et al
    MiR-1-3p and MiR-124-3p Synergistically Damage the Intestinal Barrier in the Ageing Colon.
    J Crohns Colitis. 2022;16:656-667.
    PubMed         Abstract available
    
    
28. KUCHARZIK T, Tielbeek J, Carter D, Taylor SA, et al
    ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease.
    J Crohns Colitis. 2022;16:523-543.
    PubMed         Abstract available
    
    
29. DAOUD ND, Hashash JG, Picco MF, Farraye FA, et al
    Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small Bowel Inflammation in Patients with Crohn's Disease.
    J Crohns Colitis. 2022;16:601-605.
    PubMed         Abstract available
    
    
30. BOTS S, De Voogd F, De Jong M, Ligtvoet V, et al
    Point-of-care Intestinal Ultrasound in IBD Patients: Disease Management and Diagnostic Yield in a Real-world Cohort and Proposal of a Point-of-care Algorithm.
    J Crohns Colitis. 2022;16:606-615.
    PubMed         Abstract available
    
    
31. NARULA N, Wong ECL, Colombel JF, Sandborn WJ, et al
    Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's Disease.
    J Crohns Colitis. 2022;16:616-624.
    PubMed         Abstract available
    
    
32. VERBURGT CM, Dunn KA, Van Limbergen JE
    Dietary Therapy Reduces Pro-inflammatory Microbiome Features in Paediatric Crohn's Disease.
    J Crohns Colitis. 2022;16:682-684.
    PubMed        
    
    
33. KAKUTA Y, Iwaki H, Umeno J, Kawai Y, et al
    Crohn's Disease and Early Exposure to Thiopurines are Independent Risk Factors for Mosaic Chromosomal Alterations in Patients with Inflammatory Bowel Diseases.
    J Crohns Colitis. 2022;16:643-655.
    PubMed         Abstract available
    
    
34. ROGLER G
    No Need to Scope? Monitoring of Treatment Response in IBD Patients by Transabdominal Ultrasound.
    J Crohns Colitis. 2022;16:521-522.
    PubMed        
    
    
35. CALVET X, Panes J, Gallardo-Escudero J, de la Cuadra-Grande A, et al
    Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in Spain.
    J Crohns Colitis. 2022 May 11. pii: 6584605. doi: 10.1093.
    PubMed         Abstract available
    
    
36. GOTTLIEB ZS, Sands BE
    Personalised Medicine with IL-23 Blockers: Myth or Reality?
    J Crohns Colitis. 2022;16.
    PubMed         Abstract available
    
    
37. ATREYA R, Neurath MF
    IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality.
    J Crohns Colitis. 2022;16.
    PubMed         Abstract available
    
    
38. VALENTI M, Narcisi A, Pavia G, Gargiulo L, et al
    What Can IBD Specialists Learn from IL-23 Trials in Dermatology?
    J Crohns Colitis. 2022;16.
    PubMed         Abstract available
    
    
39. MCDONALD BD, Dyer EC, Rubin DT
    IL-23 Monoclonal Antibodies for IBD: So Many, So Different?
    J Crohns Colitis. 2022;16.
    PubMed         Abstract available
    
    
40. D'AMICO F, Peyrin-Biroulet L, Danese S
    Ustekinumab in Crohn's Disease: New Data for Positioning in Treatment Algorithm.
    J Crohns Colitis. 2022;16.
    PubMed         Abstract available
    
    
41. PARIGI TL, Iacucci M, Ghosh S
    Blockade of IL-23: What is in the Pipeline?
    J Crohns Colitis. 2022;16.
    PubMed         Abstract available
    
    
42. SEWELL GW, Kaser A
    Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention.
    J Crohns Colitis. 2022;16.
    PubMed         Abstract available
    
    
43. DANESE S, Peyrin-Biroulet L
    Evolution of IL-23 Blockade in Inflammatory Bowel Disease.
    J Crohns Colitis. 2022;16.
    PubMed        
    
    

    
    Lancet Gastroenterol Hepatol

44. ROSEIRA J, Estevinho MM, Bernardo S, Sousa P, et al
    Clinical efficacy of endoscopic balloon dilation for Crohn's disease strictures.
    Lancet Gastroenterol Hepatol. 2022;7:503.
    PubMed        
    
    
45. GENERE JR, Deepak P, Kochhar GS
    Reframing self-expandable metal stents for Crohn's strictures.
    Lancet Gastroenterol Hepatol. 2022;7:503-504.
    PubMed        
    
    
46. GELDOF J, Iqbal N, LeBlanc JF, Anandabaskaran S, et al
    Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trials.
    Lancet Gastroenterol Hepatol. 2022;7:576-584.
    PubMed         Abstract available
    
    

    
    Mediators Inflamm

47. CHENG B, Rong AM, Li W, Bi X, et al
    DNMT3a-Mediated Enterocyte Barrier Dysfunction Contributes to Ulcerative Colitis via Facilitating the Interaction of Enterocytes and B Cells.
    Mediators Inflamm. 2022;2022:4862763.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: